Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Mechanism FAK inhibitors(Focal adhesion kinase inhibitors), PYK2 inhibitors(Focal adhesion kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC50H57F3N8O8 |
InChIKeyKYOUGFMQWHDXIB-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 24 Jul 2023 |